BRUSSELS, Nov 16 (Reuters) - The European Commission said the positive results announced on Monday by U.S. biotech firm Moderna for its COVID-19 vaccine candidate was encouraging and said the bloc was working to sign more supply deals with vaccine makers. “More encouraging news from #COVID19 vaccine trials w/@moderna,” EU health commissioner Stella Kyriakides said on Twitter.
“Signing contract w/ @pfizer & @BioNTech_Group later this week, more to come soon,” she added.
Last week the Commission reached a deal with Pfizer and BioNTech on the supply of their potential COVID-19 vaccine, with formal signature of the contract expected later this week. (Reporting by Francesco Guarascio @fraguarascio, editing by Louise Heavens)